arrow
L

Lova Sun

Perelman School of Medicine
H指数:27
被引数:3,663

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-Term Results of a Phase 2 Clinical Trial of Radiation Volume and Dose Deintensification Following Transoral Robotic Surgery and Neck Dissection for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma

人类乳头状瘤病毒相关口咽鳞状细胞癌行经口机器人手术及颈清扫术后,放疗体积和剂量减强度的2期临床试验长期结果

2026-09-010
PRE
Cardiac substructure radiotherapy dose and changes in physical activity and quality of life after chemoradiotherapy for NSCLC: a secondary analysis of the CLARITY prospective study cardiac substructure dose and PROs in NSCLC

非小细胞肺癌(NSCLC)化疗放疗后的心脏亚结构放射剂量以及身体活动与生活质量的变化:CLARITY前瞻性研究心脏亚结构剂量和患者报告结果(PRO)的二次分析

2025-11-120
OAAI
Safety, tolerability, and preliminary efficacy of nadunolimab, an anti-IL-1 receptor accessory protein monoclonal antibody, in combination with pembrolizumab in patients with solid tumors

安全性、耐受性及nadunolimab(一种抗IL-1受体辅助蛋白单克隆抗体)与pembrolizumab联合应用在实体瘤患者中的初步疗效

2025-05-010
OA
Tumor-intrinsic and immune-related features associated with treatment failure in human papillomavirus-related oropharyngeal cancer

与人类乳头状瘤病毒相关口咽癌治疗失败相关的肿瘤固有特征和免疫相关特征

2025-03-110
PRE
Changing Treatment and Metastatic Disease Patterns in Patients with EGFR Mutated NSCLC: An Academic Thoracic Medical Investigator's Consortium Registry Analysis

改变EGFR突变的NSCLC患者的治疗和转移性疾病模式: 学术胸科医学研究者的联盟注册分析

2025-01-010
OA
Cardiac radiation dose and changes in physical activity and quality of life in patients with locally advanced lung cancer

心脏辐射剂量及局部晚期肺癌患者身体活动与生活质量的变化

2024-11-120
PRE
Characteristics of Long-Term Survivors With EGFR-Mutant Metastatic NSCLC

EGFR突变转移性NSCLC长期存活者的特征

2024-08-012
OA
Social Determinants of Health Mediate Racial Disparities in Cardiovascular Disease in Men With Prostate Cancer
2024-06-011
OA
Plunging Into the PACIFIC: Outcomes of Patients With Unresectable KRAS-Mutated Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab Consolidation
2024-05-014
PRE
Phase 2 Trial of Consolidation Pembrolizumab After Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer
2024-05-014
PRE
Brief Report: Impact of Reflex Testing on Tissue-Based Molecular Genotyping in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
2024-05-011
PRE
Pneumonitis Rates Before and After Adoption of Immunotherapy Consolidation in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiation
2024-04-017
PRE
Patterns of Failure, Low-Volume Relapse, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer Treated With De fi nitive Chemoradiation and Consolidation Immune Checkpoint Inhibitors
2024-04-015
PRE